Checkmate Pharmaceuticals Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Checkmate Pharmaceuticals is a biotechnology research company based in Cambridge, Massachusetts. It specializes in developing approaches to harness the immune system to fight cancer, situating it in the clinical-stage immuno-oncology space. The organization operates with a small team focused on advancing immune-based oncology therapies. In 2022, Regeneron Pharmaceuticals acquired Checkmate Pharmaceuticals, integrating its operations into Regeneron's oncology program. It remains part of the broader biotechnology sector, with a focus on immuno-oncology. Its work targets oncology researchers and biopharmaceutical developers seeking immune-based cancer therapies.